(Q81183204)
Statements
Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis (English)
W H Bos
G M Bartelds
M Vis
A R van der Horst
G J Wolbink
R J van de Stadt
D van Schaardenburg
B A C Dijkmans
W F Lems
M T Nurmohamed
L Aarden